Cargando…

Potentiation of RSU-1069 tumour cytotoxicity by 5-hydroxytryptamine (5-HT).

It is known that many solid animal tumours have a lower oxygenation level than most normal tissues and, in addition, that this level of oxygenation can be further decreased by systemic administration of 5-hydroxytryptamine (5-HT). The present study has investigated if such selective decrease in tumo...

Descripción completa

Detalles Bibliográficos
Autor principal:	Chaplin, D. J.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1986
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001546/ https://www.ncbi.nlm.nih.gov/pubmed/3801269

Ejemplares similares

Distribution of pimonidazole and RSU 1069 in tumour and normal tissues.
por: Cobb, L. M., et al.
Publicado: (1990)

Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069.
por: Hill, R. P., et al.
Publicado: (1986)

Pharmacokinetics and cytotoxicity of RSU-1069 in subcutaneous 9L tumours under oxic and hypoxic conditions.
por: Wong, K. H., et al.
Publicado: (1991)

The differential cytotoxicity of RSU 1069: cell survival studies indicating interaction with DNA as a possible mode of action.
por: Stratford, I. J., et al.
Publicado: (1986)

Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.
por: Adams, G. E., et al.
Publicado: (1984)

Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. II. RSU 1069.
por: Olive, P. L.
Publicado: (1995)

Increasing the effect of photodynamic therapy on the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145.
por: Bremner, J. C., et al.
Publicado: (1992)

Phylogenetic analyses of 5-hydroxytryptamine 3 (5-HT(3)) receptors in Metazoa
por: Rao, Santosh T. R. B., et al.
Publicado: (2023)

Overexpression of human NADPH:cytochrome c (P450) reductase confers enhanced sensitivity to both tirapazamine (SR 4233) and RSU 1069.
por: Patterson, A. V., et al.
Publicado: (1997)

The effects of three bioreductive drugs (mitomycin C, RSU-1069 and SR4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation.
por: Keohane, A., et al.
Publicado: (1990)

Possible Role of 5-Hydroxytryptamine (5-HT) Receptor on Human Sperm Motility Regulation
por: Omote, Maya, et al.
Publicado: (2023)

5- Hydroxytryptamine
por: Giarman, Nicholas J.
Publicado: (1958)

Lasmiditan and 5-Hydroxytryptamine in the rat trigeminal system; expression, release and interactions with 5-HT(1) receptors
por: Edvinsson, Jacob C. A., et al.
Publicado: (2022)

5-Hydroxytryptamine (5-HT) Cellular Sequestration during Chronic Exposure Delays 5-HT(3) Receptor Resensitization due to Its Subsequent Release
por: Hothersall, J. Daniel, et al.
Publicado: (2014)

Stimulatory Effect of 5-Hydroxytryptamine (5-HT) on Rat Capsaicin-Sensitive Lung Vagal Sensory Neurons via Activation of 5-HT(3) Receptors
por: Hsu, Chun-Chun, et al.
Publicado: (2019)

Oral morphine induces spinal 5‐hydroxytryptamine (5‐HT) release using an opioid receptor‐independent mechanism
por: Nakamura, Shingo, et al.
Publicado: (2023)

Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis.
por: Miner, W. D., et al.
Publicado: (1987)

STORAGE OF 5-HYDROXYTRYPTAMINE IN MEGAKARYOCYTES
por: Tranzer, J. P., et al.
Publicado: (1972)

5-Hydroxytryptamine (5-HT) Positively Regulates Pigmentation via Inducing Melanoblast Specification and Melanin Synthesis in Zebrafish Embryos
por: Liu, Li, et al.
Publicado: (2020)

5-hydroxytryptamine (5-HT) reduces total peripheral resistance during chronic infusion: direct arterial mesenteric relaxation is not involved
por: Davis, Robert Patrick, et al.
Publicado: (2012)

Inflammatory changes in tumour vessels after systemic 5-hydroxytryptamine, bradykinin, kallikrein, or lysolecithin.
por: Cater, D. B., et al.
Publicado: (1966)

5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials
por: Pithadia, Anand B., et al.
Publicado: (2009)

5-Hydroxytryptamine 6 Receptor (5-HT(6)R)-Mediated Morphological Changes via RhoA-Dependent Pathways
por: Rahman, Md. Ataur, et al.
Publicado: (2017)

Mammary Tumour Development in BR6 Mice: Ovarian Influences and 5-Hydroxytryptamine
por: Lee, Audrey E.
Publicado: (1970)

The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694.
por: Bermudez, J., et al.
Publicado: (1988)

Regulation of Oligomeric Organization of the Serotonin 5-Hydroxytryptamine 2C (5-HT(2C)) Receptor Observed by Spatial Intensity Distribution Analysis
por: Ward, Richard J., et al.
Publicado: (2015)

5-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis
por: Jiang, Shi-Shi, et al.
Publicado: (2023)

5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia
por: Pozhidaev, Ivan V., et al.
Publicado: (2020)

Serotonin in the rat prefrontal cortex controls the micturition reflex through 5‐hydroxytryptamine 2A and 5‐hydroxytryptamine 7 receptors
por: Chiba, Hiroki, et al.
Publicado: (2020)

Physiological Control of Molluscan Gill Cilia by 5-Hydroxytryptamine
por: Gosselin, R. E., et al.
Publicado: (1962)

CHEMICAL AND ULTRASTRUCTURAL IDENTIFICATION OF 5-HYDROXYTRYPTAMINE IN AN IDENTIFIED NEURON
por: Rude, Sonia, et al.
Publicado: (1969)

5-hydroxytryptamine receptor (5-HT(1D)R) promotes colorectal cancer metastasis by regulating Axin1/β-catenin/MMP-7 signaling pathway
por: Sui, Hua, et al.
Publicado: (2015)

Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs.
por: Lash, C. J., et al.
Publicado: (1998)

Genetic characterization of novel class 1 Integrons In0, In1069 and In1287 to In1290, and the inference of In1069-associated integron evolution in Enterobacteriaceae
por: Wang, Dongguo, et al.
Publicado: (2017)

The Mechanism of Secretion and Metabolism of Gut-Derived 5-Hydroxytryptamine
por: Liu, Ning, et al.
Publicado: (2021)

The bidirectional effect of prelimbic 5-hydroxytryptamine type-4 (5-HT4) receptors on ACPA-mediated aversive memory impairment in adult male Sprague-Dawley rats
por: Ahmadi-Mahmoodabadi, Nargol, et al.
Publicado: (2021)

RIC-3 Exclusively Enhances the Surface Expression of Human Homomeric 5-Hydroxytryptamine Type 3A (5-HT(3)A) Receptors Despite Direct Interactions with 5-HT3A, -C, -D, and -E Subunits
por: Walstab, Jutta, et al.
Publicado: (2010)

Effects of 5-hydroxytryptamine on spermatozoal hyperactivation and in vitro fertilization in mice
por: SUGIYAMA, Yukiko, et al.
Publicado: (2019)

Effective treatment with combination of peripheral 5‐hydroxytryptamine synthetic inhibitor and 5‐hydroxytryptamine 2 receptor antagonist on glucocorticoid‐induced whole‐body insulin resistance with hyperglycemia
por: Ma, Shaoxin, et al.
Publicado: (2016)

STUDIES ON THE RELATIONSHIP OF 5-HYDROXYTRYPTAMINE AND THE ENTEROCHROMAFFIN CELL TO ANAPHYLACTIC SHOCK IN MICE
por: Gershon, Michael D., et al.
Publicado: (1962)

Cannot write session to /tmp/vufind_sessions/sess_4ifdvvd3q7h47idtvh6foqano8